Jalalan, Almira O.
HRN: 21-99-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2024
CEFUROXIME 750MG (VIAL)
04/20/2024
04/26/2024
IV
270mg
Q8h
PCAP B
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes